Effettuare il login Iscriviti gratis

Acelrx Pharmaceuticals Inc Short % di fluttuazione

Cos'è Short % di fluttuazione di Acelrx Pharmaceuticals Inc?

Short % di fluttuazione di Acelrx Pharmaceuticals Inc è 6.85%

Qual è la definizione di Short % di fluttuazione?



La percentuale breve di flottante è la quantità di azioni che vengono ridotte rispetto al float espresso in percentuale.

Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.

Short % di fluttuazione di aziende nel Health Care settore su NASDAQ rispetto a Acelrx Pharmaceuticals Inc

Cosa fa Acelrx Pharmaceuticals Inc?

acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v

Aziende con short % di fluttuazione simili a Acelrx Pharmaceuticals Inc